Facebook
Twitter
Telegram
Report an ErrorSarepta Therapeutics Cash Flow 2011-2024 | SRPT
Annual Cash Flow Sarepta Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-501 M | -325 M | -443 M | 107 M | -456 M | -389 M | -232 M | -246 M | - | - | -64.7 M | -29.7 M | -23.7 M |
Depreciation & Amortization |
44.4 M | 41.9 M | 38 M | 26.9 M | 24.5 M | 12.2 M | 8.09 M | 5.61 M | 5.25 M | 3.69 M | 1.28 M | 1.52 M | 1.3 M |
Accounts Payables |
165 M | 95.9 M | 76.7 M | 111 M | 68.1 M | 33.8 M | 8.47 M | 29.7 M | 20.2 M | 12.4 M | 17.6 M | 7.53 M | 9.4 M |
Accounts Receivables |
400 M | 215 M | 153 M | 101 M | 90.9 M | 49 M | 29.5 M | 5.23 M | 3.98 M | 2.42 M | 3.53 M | 4.71 M | 3.63 M |
Total Inventories |
323 M | 204 M | 186 M | 232 M | 171 M | 125 M | 83.6 M | 12.8 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Sarepta Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-242 M | - | - | - | -209 M | - | -233 M | - | -101 M | - | -414 M | - | -180 M | - | 282 M | 520 M | 628 M | - | -293 M | -225 M | -146 M | - | -266 M | -153 M | -35.7 M | - | -201 M | -143 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -15 M | - | -22.5 M | -14.7 M | -9.05 M | - | -18 M | -10.5 M | -10.1 M |
Depreciation & Amortization |
8.74 M | - | 439 K | 179 K | 11.3 M | - | 178 K | 179 K | 10.7 M | - | 27.9 M | 179 K | 8.93 M | 165 K | 19.6 M | 13 M | 6.53 M | 200 K | 17.9 M | 11.1 M | 4.88 M | 216 K | 8.72 M | 5.12 M | 2.25 M | 216 K | 5.97 M | 3.41 M | 1.64 M | 29 K | 3.95 M | 2.87 M | 1.4 M | - | 3.88 M | 2.57 M | 1.28 M | - | 2.53 M | 1.48 M | 523 K | - | 998 K | 711 K | 451 K | - | 1.09 M | 715 K | 353 K | - | 763 K | 490 K | 239 K |
Accounts Payables |
91.5 M | 165 M | 87.9 M | 110 M | 107 M | 95.9 M | 118 M | - | 54 M | 76.7 M | 44.2 M | 76.7 M | 76.7 M | 111 M | 111 M | 111 M | 111 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | 33.8 M | 33.8 M | 33.8 M | 33.8 M | 8.47 M | 8.47 M | 8.47 M | 8.47 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 8.08 M | 8.08 M | 8.08 M | 8.08 M | 7.53 M | 7.53 M | 7.53 M | 7.53 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M |
Accounts Receivables |
379 M | 400 M | 319 M | 237 M | 224 M | 215 M | 202 M | - | 178 M | 153 M | 150 M | 128 M | 118 M | 101 M | 101 M | 101 M | 101 M | 90.9 M | 90.9 M | 90.9 M | 90.9 M | 49 M | 49 M | 49 M | 49 M | 29.5 M | 29.5 M | 29.5 M | 29.5 M | 5.23 M | 5.23 M | 5.23 M | 5.23 M | 3.98 M | 3.98 M | 3.98 M | 3.98 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 3.53 M | 3.53 M | 3.53 M | 3.53 M | 4.71 M | 4.71 M | 4.71 M | 4.71 M | 3.63 M | 3.63 M | 3.63 M | 3.63 M |
Total Inventories |
374 M | 323 M | 244 M | 227 M | 203 M | 204 M | 221 M | - | 199 M | 186 M | 288 M | 269 M | 240 M | 232 M | 232 M | 232 M | 232 M | 171 M | 171 M | 171 M | 171 M | 125 M | 125 M | 125 M | 125 M | 83.6 M | 83.6 M | 83.6 M | 83.6 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency